These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 20499414)

  • 1. The influence of Sam-Chil-Geun (Panax notoginseng) on the serum lipid levels and inflammations of rats with hyperlipidemia induced by poloxamer-407.
    Joo IW; Ryu JH; Oh HJ
    Yonsei Med J; 2010 Jul; 51(4):504-10. PubMed ID: 20499414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of atorvastatin and carboxymethylated glucan on the serum lipoprotein profile and MMP activity of mice with lipemia induced by poloxamer 407.
    Korolenko TA; Tuzikov FV; Cherkanova MS; Johnston TP; Tuzikova NA; Loginova VM; Filjushina EE; Kaledin VI
    Can J Physiol Pharmacol; 2012 Feb; 90(2):141-53. PubMed ID: 22320860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the lipid lowering ability, anti-inflammatory effects and clinical safety of intensive therapy with Zhibitai, a Chinese traditional medicine.
    Xu DY; Shu J; Huang QY; Wasti B; Chen C; Liu L; Zhao SP
    Atherosclerosis; 2010 Jul; 211(1):237-41. PubMed ID: 20189174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of triangle drugs as ginseng, Trichosanthes kirilowii maxim and rhubarb on the level of blood lipids and related pro-inflammatory cytokines during the process of treating atherosclerosis].
    Wang JY; Wu SX; Jiang LD
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2011 May; 31(5):667-71. PubMed ID: 21812271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Efficacy and safety of extended-release niacin alone or with atorvastatin for lipid profile modification].
    Li XP; Duan J; Zhao SP; Tan MY; Xu ZM; Zhang DQ
    Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(34):2399-403. PubMed ID: 17156651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of combined hyperlipidemia patients by jiangzhi tongluo soft capsule combined atorvastatin calcium tablet: a clinical study].
    Xie Y; He YB; Zhang SX; Pan AQ; Zhang J; Guan XH; Wang JX; Guo WS
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2014 Sep; 34(9):1059-63. PubMed ID: 25335328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The beneficial effects of lipid-lowering drugs beyond lipid-lowering effects: a comparative study with pravastatin, atorvastatin, and fenofibrate in patients with type IIa and type IIb hyperlipidemia.
    Saklamaz A; Comlekci A; Temiz A; Caliskan S; Ceylan C; Alacacioglu A; Yesil S
    Metabolism; 2005 May; 54(5):677-81. PubMed ID: 15877299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intervention Effects of Atorvastatin Combined with
    Jiang QF; Huang MY; Wu KY; Weng JL; Deng RG; Xu XJ; Xu JP; Jiang T
    Pharmacogn Mag; 2017; 13(51):430-438. PubMed ID: 28839368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of multiple neurotransmitters in the effects of Lycopene on brain injury induced by Hyperlipidemia.
    Yang W; Shen Z; Wen S; Wang W; Hu M
    Lipids Health Dis; 2018 Feb; 17(1):13. PubMed ID: 29409499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antihyperlipidemic effect of Cyclocarya paliurus (Batal.) Iljinskaja extract and inhibition of apolipoprotein B48 overproduction in hyperlipidemic mice.
    Ma Y; Jiang C; Yao N; Li Y; Wang Q; Fang S; Shang X; Zhao M; Che C; Ni Y; Zhang J; Yin Z
    J Ethnopharmacol; 2015 May; 166():286-96. PubMed ID: 25794806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized trial of the effects of atorvastatin and niacin in patients with combined hyperlipidemia or isolated hypertriglyceridemia. Collaborative Atorvastatin Study Group.
    McKenney JM; McCormick LS; Weiss S; Koren M; Kafonek S; Black DM
    Am J Med; 1998 Feb; 104(2):137-43. PubMed ID: 9528731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of aggressive versus standard lipid lowering by atorvastatin on diabetic dyslipidemia: the DALI study: a double-blind, randomized, placebo-controlled trial in patients with type 2 diabetes and diabetic dyslipidemia.
    Diabetes Atorvastin Lipid Intervention (DALI) Study Group
    Diabetes Care; 2001 Aug; 24(8):1335-41. PubMed ID: 11473066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in flow-mediated dilatation, cytokines and carotid arterial stenosis during aggressive atorvastatin treatment in normocholesterolemic patients.
    Hsu HY; Wang PY; Chen YT; Sheu WH; Hu HH; Sheng WY
    J Chin Med Assoc; 2005 Feb; 68(2):53-8. PubMed ID: 15759815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the efficacy of atorvastatin and micronized fenofibrate in the treatment of mixed hyperlipidemia.
    Bairaktari ET; Tzallas CS; Tsimihodimos VK; Liberopoulos EN; Miltiadous GA; Elisaf MS
    J Cardiovasc Risk; 1999 Apr; 6(2):113-6. PubMed ID: 10353071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of statins (atorvastatin) on serum lipoprotein levels in patients with primary hyperlipidemia and coronary heart disease.
    Jurukovska-Nospal M; Arsova V; Levchanska J; Sidovska-Ivanovska B
    Prilozi; 2007 Dec; 28(2):137-48. PubMed ID: 18356785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Danlou Tablet Fought against Inflammatory Reaction in Atherosclerosis Rats with Intermingled Phlegm and Blood Stasis Syndrome and Its Mechanism Study].
    Chen J; Cai HW; Miao J; Xu XM; Mao W
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2016 Jun; 36(6):703-8. PubMed ID: 27491230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Icariin Attenuates High-cholesterol Diet Induced Atherosclerosis in Rats by Inhibition of Inflammatory Response and p38 MAPK Signaling Pathway.
    Hu Y; Sun B; Liu K; Yan M; Zhang Y; Miao C; Ren L
    Inflammation; 2016 Feb; 39(1):228-236. PubMed ID: 26307750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of a combination of calorie-restriction therapy and Lingguizhugan decoction on levels of fasting blood lipid and inflammatory cytokines in a high-fat diet induced hyperlipidemia rat model.
    Yuanyuan W; Minghua J; Lina Z; Suhua L; Jiayu Z; Yongzhi S; Chunyu C; Jian Q
    J Tradit Chin Med; 2015 Apr; 35(2):218-21. PubMed ID: 25975056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypolipidemic effects of Sophora flavescens and its constituents in poloxamer 407-induced hyperlipidemic and cholesterol-fed rats.
    Kim HY; Jeong DM; Jung HJ; Jung YJ; Yokozawa T; Choi JS
    Biol Pharm Bull; 2008 Jan; 31(1):73-8. PubMed ID: 18175945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of short-term atorvastatin treatment on global fibrinolytic capacity, and sL-selectin and sFas levels in hyperlipidemic patients with coronary artery disease.
    Atalar E; Ozmen F; Haznedaroglu I; Açil T; Ozer N; Ovünç K; Aksöyek S; Kes S
    Int J Cardiol; 2002 Aug; 84(2-3):227-31. PubMed ID: 12127376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.